[28-09-am] Pharmacotherapy (Oncology) | The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[28-09-am]Pharmacotherapy (Oncology)

Fri. Mar 28, 2025 10:10 AM - 11:46 AM JST
Fri. Mar 28, 2025 1:10 AM - 2:46 AM UTC

Room 9 (Fukuoka International Congress Center: 411 [4F])

Chair: Ryuji Ikeda, Takashi Kitahara

10:10 AM - 10:22 AM JST(1:10 AM - 1:22 AM UTC)

[28-09-am07S]Impact of co-administration of gastric acid suppressants on the effectiveness of CDK4/6 inhibitors in patients with endocrine-sensitive breast cancer

○Kaori Takahashi¹, Ryuji Uozumi², Toru Mukohara³, Shinya Takada⁴, Tetsu Hayashida⁵, Midori Iwabe⁶, Hirotoshi Iihara⁷, Kanako Kusuhara⁸, Kanae Tahatsu⁴, Aiko Nagayama⁵, Masami Tsuchiya¹, Mika Kitahora⁷, Kengo Umehara⁴, Tomoko Seki⁵, Shinkichi Kosaka⁹, Yoshimi Niwa¹⁰, Kenichi Watanabe¹¹, Koji Ohnuki¹², Manabu Futamura¹⁰, Hitoshi Kawazoe⁵, Tomonori Nakamura¹ (1. Keio Univ. Fac. Pharm., 2. Dept. Ind. Eng. and Econ.,Science Tokyo, 3. Dept. Med. Oncol., NCCE, 4. Dept. Pharm., National Hosp. Org. Hokkaido Cancer Center, 5. Keio Univ. Sch. Med., 6. Dept. Pharm., Miyagi Cancer Center, 7. Dept. Pharm., Gifu Univ. Hosp., 8. Dept. Pharm., NCCE, 9. Dept. Surg., National Hosp. Org. Mito Medical Center, 10. Dept. Breast Surg., Gifu Univ. Hosp., 11. Dept. Breast Surg., National Hosp. Org. Hokkaido Cancer Center, 12. Dept. Breast Surg., Miyagi Cancer Center)

10:22 AM - 10:34 AM JST(1:22 AM - 1:34 AM UTC)

[28-09-am08]Examination of inflammation-related polymorphisms involved in regorafenib-induced hand-foot skin reactions.

○Remi Murase¹, Natsumi Matsumoto¹, Yutaro Kubota², Hiroo Ishida³, Ken-ichi Fujita¹ (1. Showa Univ. Grad. Sch. Pharm., 2. Showa Univ. Hosp., 3. Showa Univ. Northern Yokohama Hosp.)

10:34 AM - 10:46 AM JST(1:34 AM - 1:46 AM UTC)

[28-09-am09S]Association of polymorphisms in genes encoding immune response-related factors and regorafenib-induced erythema multiforme in patients with advanced colorectal cancer

○Geonwoo Lee¹, Remi Murase¹, Natsumi Matsumoto¹, Yutaro Kubota², Hiroo Ishida³, Ken-ichi Fujita¹ (1. Showa Univ. Grad. Sch. Pharm., 2. Showa Univ. Hosp., 3. Showa Univ. Northern Yokohama Hosp.)

10:46 AM - 10:58 AM JST(1:46 AM - 1:58 AM UTC)

[28-09-am10S]Chronopharmacological approach for optimization of the dose schedule of the HER2-targeted antibody drug conjugate, Trastuzumab-Deruxtecan

○Sayaka Takeda¹, Nakao Nodoka¹, Tomoaki Yamauchi¹, Mai Haraguchi¹, Yuji Omata¹, Akito Tsuruta¹, Satoru Koyanagi¹ (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)

10:58 AM - 11:10 AM JST(1:58 AM - 2:10 AM UTC)

[28-09-am11S]Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab, and the role of pharmacists: a single-center retrospective study

○Mai Amano¹, Miki Yamada², Yosuke Iijima², Shunsuke Hino², Hiroshi Sakagami³, Norio Horie², Takahiro Kaneko², Motohiko Sano¹ (1. Division of Applied Pharmaceutical Education and Research Hoshi University, 2. Department of Oral and Maxillofacial Surgery, Saitama Medical Center, Saitama Medical University, 3. Meikai University Research Institute of Odontology (M-RIO))

11:10 AM - 11:22 AM JST(2:10 AM - 2:22 AM UTC)

[28-09-am12S]Efficacy of 5-HT₃ RA administration for chemotherapy-induced nausea and vomiting in patients received chemoradiotherapy treated with concomitant temozolomide

○Yurie Ono¹, Kumiko Sekiya², Daichi Watanabe², Sakika Goto², Taishi Yamamoto², Manami Otsubo², Tomoya Kitagawa², Naoyuki Ohe³, Noriyuki Nakayama³, Takeshi Izumo³, Hironori Fujii², Hirotoshi Iihara², Ryo Kobayashi^1,2, Akio Suzuki^1,2 (1. Gifu. Pharm. Univ. , 2. Dept. Pharm. Gifu. Univ. Hosp., 3. Grad. Sch. Med., Gifu Univ.)

11:22 AM - 11:34 AM JST(2:22 AM - 2:34 AM UTC)

[28-09-am13S]Cumulative Incidence of Cancer Cachexia and Its Prognostic Implications in Patients with Colorectal Cancer: A Retrospective Study Using EPCRC and AWGC Criteria

○Misato Kani¹, Yuto Miura¹, Daichi Watanabe², Hironori Fujii², Yunami Yamada², Koichi Ohata², Chiemi Hirose², Hirotoshi Iihara², Wakana Chikaishi³, Jesse Yu Tajima³, Akiyoshi Makiyama⁴, Nobuhisa Matsuhashi³, Ryo Kobayashi¹, Akio Suzuki^1,2 (1. Gifu. Pharm. Univ., 2. Dept. Pharm. Gifu. Univ. Hosp., 3. Grad.Sch.Med.Gifu Univ., 4. Cancer Cent. Gifu Univ.Hosp.)

11:34 AM - 11:46 AM JST(2:34 AM - 2:46 AM UTC)

[28-09-am14S]Survey of Perioperative Treatment in Muscle-Invasive Urothelial Carcinoma Using Japanese Hospital-Based Claims Database

○Ayumi Yamazawa¹, Masami Tsuchiya¹, Keisuke Ikegami¹, Shungo Imai¹, Hayato Kizaki¹, Satoko Hori¹ (1. Keio Univ. Pharm.)

Back to Category List